This Article was originally published on Invimeds The US Food and Drug Administration (FDA) has …
A randomized, open-label phase 3 trial (LITESPARK-005, ClinicalTrials.gov, NCT04195750) investi…
Gilead’s Sciences announced the promising activity of Trodelvy (sacituzumab govitecan-hziy) i…
The clinical trial HER2CLIMB-02 conducted on Tukysa (Tucatinib) in combination with Kadycyla…
B-cell Acute lymphoblastic leukemia (B-cell ALL) is an aggressive type of blood cancer and is v…